| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Lai,Jia-De | Chairman | 1.40% | SHANG SHUN INVESTMENT CO., LTD. |
| Liu,You-Ci | Vice Chairman | 0.52% | |
| Chen,Qing-Biao | Director | 4.66% | HE QUN INVESTMENT CO., LTD. |
| Wang,Zhen-Gang | Director | 4.34% | TING FA INVESTMENT CO., LTD. |
| Xu,Jin-Yuan | Director | 1.33% | BEI XI Co., Ltd. |
| Lan,Shi-Wan | Director | 0.56% | |
| Hou,Qi-Zheng | Director | 0.02% | |
| Lin,Shi-Yi | Independent Director | 0.00% | |
| He,Li-Fen | Independent Director | 0.04% | |
| Lv,Jing-Jun | Independent Director | 0.00% | |
| Chen,Gu-Quan | Independent Director | 0.00% |
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 412,374 | 1,670,033 | 1,191,985 |
| Operating cost | 308,516 | 1,394,378 | 995,101 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 103,858 | 275,655 | 196,884 |
| Unrealized profit (loss) on sales of goods | 0 | 0 | 6,293 |
| Realized profit (loss) on sales of goods | 0 | 6,293 | 13,720 |
| Operating gross profit (loss), net | 103,858 | 281,948 | 204,311 |
| Operating expenses | 82,385 | 224,735 | 216,373 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 21,473 | 57,213 | -12,062 |
| Non-operating income and expenses | 16,283 | 69,897 | 20,088 |
| Net profit (loss) before tax | 37,756 | 127,110 | 8,026 |
| Income tax expense (benefits) | 9,690 | 20,791 | 9,620 |
| Net profit (loss) of ongoing business for the current period | 28,066 | 106,319 | -1,594 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 28,066 | 106,319 | -1,594 |
| Other comprehensive profit (loss), net | 3,786 | 3,908 | -18,990 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 31,852 | 110,227 | -20,584 |
| Net profit (loss) attributable to owners of parent company | 24,794 | 93,975 | 2,948 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | 3,272 | 12,344 | -4,542 |
| Comprehensive profit (loss) attributable to owners of parent company | 26,281 | 97,883 | -16,042 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | 5,571 | 12,344 | -4,542 |
| Basic earnings per share (yuan) | 0 | 0 | 0 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 35,262 | 65,903 | 2,933 |
| Net cash inflows (outflows) from investing activities | -141,040 | -444,928 | -358,382 |
| Net cash inflow (outflow) from financing activities | 128,996 | 338,025 | 82,063 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 1,114 | -4,575 | - |
| Increase (decrease) in cash and cash equivalents in the current period | 24,332 | -45,575 | -273,386 |
| Beginning balance of cash and cash equivalents | 277,458 | 323,033 | 596,419 |
| Ending balance of cash and cash equivalents | 301,790 | 277,458 | 323,033 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 1,502,809 | 1,472,665 | 1,317,351 |
| Non-current asset | 2,315,334 | 2,222,654 | 1,750,007 |
| Total asset | 3,818,143 | 3,695,319 | 3,067,358 |
| Current liability | 787,230 | 744,764 | 578,133 |
| Non-current liability | 477,673 | 383,638 | 94,131 |
| Total liability | 1,264,903 | 1,128,402 | 672,264 |
| share capital | 1,470,592 | 1,470,592 | 1,457,698 |
| Equity - secruity token | - | - | - |
| capital reserve | 890,594 | 890,594 | 922,286 |
| retained earning | 228,208 | 247,529 | 158,058 |
| Other equity | -110,265 | -116,642 | -140,193 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 2,479,129 | 2,492,073 | 2,397,849 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 74,111 | 74,844 | -2,755 |
| Total Equity | 2,553,240 | 2,566,917 | 2,395,094 |
| Share capital awaiting retirement (unit: share) | 0 | 0 | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 16 | 16 | 16 |
| 標案名稱 | 機關名稱 | 決標日期 | 決標金額 | 是否得標 |
|---|---|---|---|---|
| 可充式電池組乙項 | 國防部陸軍司令部 | 105/05/27 | 否 | |
| 血糖試紙及採血針等2項 | 臺北榮民總醫院桃園分院 | 102/10/23 | 否 |
